No islets left behind: Islet autotransplantation for surgery-induced diabetes

Current Diabetes Reports

Volumn 12, Issue 5, 2012, Pages 580-586

  Bellin, Melena D ^a   Balamurugan, A N ^b   Pruett, Timothy L ^a   Sutherland, David E R ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Alpha cell; Autotransplant; Beta cell; C peptide; Chronic Pancreatitis; Diabetes mellitus; Islet transplant; Pancreatectomy; Pancreatitis; Surgery

Indexed keywords

C PEPTIDE; HEMOGLOBIN A1C; INSULIN;

ARTICLE; AUTOTRANSPLANTATION; CHRONIC PANCREATITIS; DIABETES MELLITUS; ENGRAFTMENT; GLYCEMIC CONTROL; HUMAN; INSULIN RELEASE; INSULIN TREATMENT; LAPAROSCOPIC SURGERY; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PANCREAS ISLET TRANSPLANTATION; PANCREAS RESECTION; POSTOPERATIVE PERIOD; SURGICAL TECHNIQUE; THERAPY EFFECT;

DIABETES MELLITUS; HUMANS; ISLETS OF LANGERHANS TRANSPLANTATION; PANCREATECTOMY; PANCREATITIS, CHRONIC;

EID: 84870808294     PISSN: 15344827     EISSN: 15390829     Source Type: Journal    
DOI: 10.1007/s11892-012-0296-1     Document Type: Article

References (65)

1. Blondet JJ, Carlson AM, Kobayashi T, et al. The role of total pancreatectomy and islet autotransplantation for chronic pancreatitis. Surg Clin N Am. 2007;87:1477-501. (Pubitemid 350160791)
2. Ahmad SA, Lowy AM, Wray CJ, et al. Factors associated with insulin and narcotic independence after islet autotransplantation in patients with severe chronic pancreatitis. J Am Coll Surg. 2005;201:680-7. (Pubitemid 41539759)
3. Dixon J, DeLegge M, Morgan KA, Adams DB. Impact of total pancreatectomy with islet cell transplant on chronic pancreatitis management at a disease-based center. Am Surg. 2008;74:735-8.
4. Webb MA, Illouz SC, Pollard CA, et al. Islet auto transplantation following total pancreatectomy: a long-term assessment of graft function. Pancreas. 2008;37:282-7.
5. Sutton JM, Schmulewitz N, Sussman JJ, et al. Total pancreatectomy and islet cell autotransplantation as a means of treating patients with genetically linked pancreatitis. Surgery. 2010;148:676-85. discussion 685-676.
6. Morgan KA, Nishimura M, Uflacker R, Adams DB. Percutaneous transhepatic islet cell autotransplantation after pancreatectomy for chronic pancreatitis: a novel approach. HPB (Oxford). 2011;13:511-6.
7. Morgan K, Owczarski SM, Borckardt J, et al. Pain control and quality of life after pancreatectomy with islet autotransplantation for chronic pancreatitis. J Gastrointest Surg. 2012;16:129-33. discussion 133-24.
8. Sutherland DE, Radosevich DM, Bellin MD, et al. Total pancreatectomy and islet autotransplantation for chronic pancreatitis. J Am Coll Surg. 2012;214:409-24.
9. Ahmed SA, Wray C, Rilo HL, et al. Chronic pancreatitis: recent advances and ongoing challenges. Curr Probl Surg. 2006;43:127-238.
10. Kobayashi T, Manivel JC, Carlson AM, et al. Correlation of histopathology, islet yield, and islet graft function after islet autotransplantation in chronic pancreatitis. Pancreas. 2011;40:193-9.
11. Kobayashi T, Manivel JC, Bellin MD, et al. Correlation of pancreatic histopathologic findings and islet yield in children with chronic pancreatitis undergoing total pancreatectomy and islet autotransplantation. Pancreas. 2010;39:57-63.
12. Howes N, Lerch MM, Greenhalf W, et al. Clinical and genetic characteristics of hereditary pancreatitis in Europe. Clin Gastroenterol Hepatol. 2004;2:252-61. (Pubitemid 38293313)
13. Ammann RW. Diagnosis and management of chronic pancreatitis: current knowledge. Swiss Med Wkly. 2006;136:166-74.
14. Bhardwaj P, Garg PK, Maulik SK, et al. A randomized controlled trial of antioxidant supplementation for pain relief in patients with chronic pancreatitis. Gastroenterology. 2009;136(1):149-59.e2.
15. Choudari CP, Nickl NJ, Fogel E, et al. Hereditary pancreatitis: clinical presentation, ERCP findings, and outcome of endoscopic therapy. Gastrointest Endosc Clin N Am. 2002;56:66-71. (Pubitemid 41115051)
16. Oberholzer J, Mathe Z, Bucher P, et al. Islet autotransplantation after left pancreatectomy for non-enucleable insulinoma. Am J Transplant. 2003;3:1302-7. (Pubitemid 37214628)
17. Berney T, Mathe Z, Bucher P, et al. Islet autotransplantation for the prevention of surgical diabetes after extended pancreatectomy for the resection of benign tumors of the pancreas. Transplant Proc. 2004;36:1123-4. (Pubitemid 38766297)
18. Lee BW, Jee JH, Heo JS, et al. The favorable outcome of human islet transplantation in Korea: experiences of 10 autologous transplantations. Transplantation. 2005;79:1568-74.
19. Ris F, Niclauss N, Morel P, et al. Islet autotransplantation after extended pancreatectomy for focal benign disease of the pancreas. Transplantation. 2011;91:895-901.
20. Jindal RM, Ricordi C, Shriver CD. Autologous pancreatic islet transplantation for severe trauma. N Engl J Med. 2010;362:1550.
21. Khan A, Jindal RM, Shriver C, et al. Remote processing of pancreas can restore normal glucose homeostasis in autologous islet transplantation after traumatic whipple pancreatectomy: technical considerations. Cell Transplant. 2011. doi:10.3727/096368911x600984
22. Giulianotti P, Gorodner V, Kinzer K, et al. Robot-assisted pancreatoduodenectomy with preservation of the vascular supply for autologous islet cell isolation and transplantation: a case report. J Med Case Rep. 2012;6:74.
23. Marquez S, Marquez TT, Ikramuddin S, et al. Laparoscopic and da Vinci robot-assisted total pancreaticoduodenectomy and intraportal islet autotransplantation: case report of a definitive minimally invasive treatment of chronic pancreatitis. Pancreas. 2010;39:1109-11.
24. Anazawa T, Matsumoto S, Yonekawa Y, et al. Prediction of pancreatic tissue densities by an analytical test gradient system before purification maximizes human islet recovery for islet autotransplantation/ allotransplantation. Transplantation. 2011;91:508-14.
25. Lakey JR, Warnock GL, Shapiro AM, et al. Intraductal collagenase delivery into the human pancreas using syringe loading or controlled perfusion. Cell Transplant. 1999;8:285-92. (Pubitemid 29350224)
26. Ricordi C, Lacy PE, Scharp DW. Automated islet isolation from human pancreas. Diabetes. 1989;38 Suppl 1:140-2. (Pubitemid 19029262)
27. Matsumoto S, Takita M, Shimoda M, et al. Impact of tissue volume and purification on clinical autologous islet transplantation for the treatment of chronic pancreatitis. Cell Transplant. 2012. doi:10.3727/096368911x623899
28. Wilhelm JJ, Bellin MD, Balamurugan AN, et al. A proposed threshold for dispersed-pancreatic tissue volume infused during intraportal islet autotransplantation after total pancreatectomy to treat chronic pancreatitis. Pancreas. 2011;40:1363.
29. Lake SP, Bassett PD, Larkins A, et al. Large-scale purification of human islets utilizing discontinuous albumin gradient on IBM 2991 cell separator. Diabetes. 1989;38 Suppl 1:143-5. (Pubitemid 19029263)
30. Ricordi C, Gray DW, Hering BJ, et al. Islet isolation assessment in man and large animals. Acta Diabetol Lat. 1990;27:185-95. (Pubitemid 20367488)
31. Bellin MD, Freeman ML, Schwarzenberg SJ, et al. Quality of life improves for pediatric patients after total pancreatectomy and islet autotransplant for chronic pancreatitis. Clin Gastroenterol Hepatol. 2011;9:793-9.
32. Rafael E, Tibell A, Ryden M, et al. Intramuscular autotransplantation of pancreatic islets in a 7-year-old child: a 2-year follow-up. Am J Transplant. 2008;8:458-62.
33. First MR, Gerber DA, Hariharan S, et al. Posttransplant diabetes mellitus in kidney allograft recipients: incidence, risk factors, and management. Transplantation. 2002;73:379-86. (Pubitemid 34174287)
34. Nir T, Melton DA, Dor Y. Recovery from diabetes in mice by beta cell regeneration. J Clin Invest. 2007;117:2553-61. (Pubitemid 47494356)
35. Noguchi H. Activation of c-Jun NH2-terminal kinase during islet isolation. Endocr J. 2007;54:169-76. (Pubitemid 46798638)
36. Abdelli S, Ansite J, Roduit R, et al. Intracellular stress signaling pathways activated during human islet preparation and following acute cytokine exposure. Diabetes. 2004;53:2815-23. (Pubitemid 39425906)
37. Hathout E, Chan NK, Tan A, et al. In vivo imaging demonstrates a time-line for new vessel formation in islet transplantation. Pediatr Transplant. 2009;13:892-7.
38. Speier S, Nyqvist D, Cabrera O, et al. Noninvasive in vivo imaging of pancreatic islet cell biology. Nat Med. 2008;14:574-8. (Pubitemid 351655207)
39. Biarnes M, Montolio M, Nacher V, et al. Beta-cell death and mass in syngeneically transplanted islets exposed to short-and longterm hyperglycemia. Diabetes. 2002;51:66-72. (Pubitemid 34517981)
40. Finzi G, Davalli A, Placidi C, et al. Morphological and ultrastructural features of human islet grafts performed in diabetic nude mice. Ultrastruct Pathol. 2005;29:525-33. (Pubitemid 41769940)
41. Paraskevas S, Maysinger D, Wang R, et al. Cell loss in isolated human islets occurs by apoptosis. Pancreas. 2000;20:270-6. (Pubitemid 30171780)
42. Davalli AM, Scaglia L, Zangen DH, et al. Vulnerability of islets in the immediate posttransplantation period. Dynamic changes in structure and function. Diabetes. 1996;45:1161-7. (Pubitemid 26296313)
43. Prentki M, Nolan CJ. Islet beta cell failure in type 2 diabetes. J Clin Invest. 2006;116:1802-12. (Pubitemid 44033300)
44. Bonora E. Protection of pancreatic beta-cells: is it feasible? NMCD. 2008;18:74-83. (Pubitemid 50020512)
45. Matsumoto S, Takita M, Shimoda M, et al. Usefulness of the secretory unit of islet transplant objects (SUITO) index for evaluation of clinical autologous islet transplantation. Transplant Proc. 2011;43:3246-9.
46. Sutherland DE, Gruessner AC, Carlson AM, et al. Islet autotransplant outcomes after total pancreatectomy: a contrast to islet allograft outcomes. Transplantation. 2008;86:1799-802.
47. Sutherland DE, Carlson AM, Blondet JJ, et al. Islet autotransplantation- long-term results and lessons learned that could be applied to islet allotransplantation. Xenotransplantation. 2007;14:391.
48. Robertson RP, Lanz KJ, Sutherland DE, Kendall DM. Prevention of diabetes for up to 13 years by autoislet transplantation after pancreatectomy for chronic pancreatitis. Diabetes. 2001;50:47-50. (Pubitemid 32047979)
49. Bellin MD, Blondet JJ, Beilman GJ, et al. Predicting islet yield in pediatric patients undergoing pancreatectomy and autoislet transplantation for chronic pancreatitis. Pediatr Diabetes. 2010;11:227-34.
50. Takita M, Naziruddin B, Matsumoto S, et al. Variables associated with islet yield in autologous islet cell transplantation for chronic pancreatitis. Proc (Baylor Univ Med Cent). 2010;23:115-20.
51. Takita M, Naziruddin B, Matsumoto S, et al. Body mass index reflects islet isolation outcome in islet autotransplantation for patients with chronic pancreatitis. Cell Transplant. 2011;20:313-22.
52. Balamurugan AN, Loganathan G, Bellin MD, et al. A new enzyme mixture to increase the yield and transplant rate of autologous and allogeneic human islet products. Transplantation. 2012;93:693-702.
53. Bellin MD, Carlson AM, Kobayashi T, et al. Outcome after pancreatectomy and islet autotransplantation in a pediatric population. J Pediatr Gastroenterol Nutr. 2008;47:37-44.
54. Meier JJ, Butler AE, Saisho Y, et al. Beta-cell replication is the primary mechanism subserving the postnatal expansion of betacell mass in humans. Diabetes. 2008;57:1584-94.
55. Soltani SM, O'Brien TD, Loganathan G, et al. Severely fibrotic pancreases from young patients with chronic pancreatitis: evidence for a ductal origin of islet neogenesis. Acta Diabetol. 2011. doi:10.1007/s00592-011-0306-9
56. Teuscher AU, Kendall DM, Smets YF, et al. Successful islet autotransplantation in humans: functional insulin secretory reserve as an estimate of surviving islet cell mass. Diabetes. 1998;47:324-30. (Pubitemid 28104191)
57. Meier JJ, Hong-McAtee I, Galasso R, et al. Intrahepatic transplanted islets in humans secrete insulin in a coordinate pulsatile manner directly into the liver. Diabetes. 2006;55:2324-32. (Pubitemid 44743631)
58. Bellin MD, Sutherland DE, Beilman GJ, et al. Similar islet function in islet allotransplant and autotransplant recipients, despite lower islet mass in autotransplants. Transplantation. 2011;91:367-72.
59. Kendall DM, Teuscher AU, Robertson RP. Defective glucagon secretion during sustained hypoglycemia following successful islet allo-and autotransplantation in humans. Diabetes. 1997;46:23-7. (Pubitemid 27009944)
60. Gupta V, Wahoff DC, Rooney DP, et al. The defective glucagon response from transplanted intrahepatic pancreatic islets during hypoglycemia is transplantation site-determined. Diabetes. 1997;46:28-33. (Pubitemid 27009945)
61. Zhou H, Zhang T, Bogdani M, et al. Intrahepatic glucose flux as a mechanism for defective intrahepatic islet alpha-cell response to hypoglycemia. Diabetes. 2008;57:1567-74.
62. Bottino R, Balamurugan AN, Tse H, et al. Response of human islets to isolation stress and the effect of antioxidant treatment. Diabetes. 2004;53:2559-68. (Pubitemid 39299262)
63. Moberg L. The role of the innate immunity in islet transplantation. Ups J Med Sci. 2005;110:17-55. (Pubitemid 40342459)
64. Bennet W, Groth CG, Larsson R, et al. Isolated human islets trigger an instant blood mediated inflammatory reaction: implications for intraportal islet transplantation as a treatment for patients with type 1 diabetes. Ups J Med Sci. 2000;105:125-33.
65. Christoffersson G, Henriksnas J, Johansson L, et al. Clinical and experimental pancreatic islet transplantation to striated muscle: establishment of a vascular system similar to that in native islets. Diabetes. 2010;59:2569-78.